We are live on
!
Find out more
Corvus Pharmaceuticals
CRVS
CRVS
61 hedge funds and large institutions have $92.2M invested in Corvus Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
44% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 16
0% more funds holding
Funds holding: 61 → 61 (0)
0% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 8
1.86% less ownership
Funds ownership: 87.69% → 85.83% (-1.9%)
58% less capital invested
Capital invested by funds: $219M → $92.2M (-$127M)
Holders
61
Holders Change
–
Holders Change %
0%
% of All Funds
1.36%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
8
Increased
23
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
PCM
Puissance Capital Management
New York
|
+$1.94M |
| 2 |
Renaissance Technologies
New York
|
+$1.81M |
| 3 |
FI
Fosun International
Hong Kong,
China
|
+$1.08M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.01M |
| 5 |
TI
Telemetry Investments
New York
|
+$921K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.67M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.04M |
| 3 |
BlackRock
New York
|
-$1.77M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$1.19M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$710K |
